Please login to the form below
Latest white papers and resources on PMHub
Listed below are the latest white papers and thought leadership submitted by suppliers using PMHub to promote their services to our international pharma audience. If you would like to be included within PMHub, please click the ‘Add my Company’ link.
-
Patient journey mapping: exploring the clinical and the emotional journey
By Chris Hodgson, Neil Rees, Sumira Riaz and Karen Petticrew While we can all agree that the value of developing a patient journey map cannot be underestimated when exploring the care pathway for a patient, there appear to be inconsistencies within the same pharmaceutical organisations as to how patient journey mapping is defined. Submitted by: OPEN Health -
Precision medicine at Blue Latitude Health
At Blue Latitude Health we have identified 90+ insights about commercialising precision medicines. Check out our video to get a run down on three core components of the commercialisation and launch of precision medicines. Submitted by: Blue Latitude Health -
Understanding the evolving CAR-T market
In 2017 the approval of the first CAR-T treatment took the world by storm, transforming the way cancer is treated, but two years later more than 500 CAR-Ts are in development. So how can pharma ensure its product stands out from the crowd? Submitted by: Blue Latitude Health -
RWE Blog 2: Payers use real-world data cautiously
Following our evaluation of the role of real-world data (RWD) and real-world evidence (RWE) in our blog Real-world challenges and real-world data, the second instalment of our four-blog series looks at why payers use real-world data cautiously. Submitted by: Valid Insight -
The role of gratitude in clinical trials
In this blog, we discuss the meaning of gratitude, while asking what does it mean to say thank you to your clinical trial participants? Submitted by: COUCH Health -
RWE Blog 1: Real-world challenges and real-world data
This is the first of a set of four blogs on real-world data (RWD) and real-world-evidence (RWE), and their role in market access. Submitted by: Valid Insight -
Article: Market access in Brazil
All eyes on Spinraza Submitted by: Research Partnership -
China: How to strategise and win in the world's fastest changing healthcare market
Submitted by: Research Partnership -
Infographic: Preparing to launch a new asset and in need of demand assessment research?
Download our pre-launch checklist Submitted by: Research Partnership -
How ready are you for launch?
Pharmaceutical launches are becoming more complex and competitive. Our launch excellence diagnostic tool helps you to map how ready you are for launch, while facilitating success in this challenging environment. Submitted by: Blue Latitude Health
Featured jobs
-
Senior Medical Writer
-
Salary TBC
-
Account Executive
-
Salary TBC
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
- Scientific Director - Medical Communications - Berkshire
-
Excellent package on offer
-
Account Supervisor
-
Salary TBC
-
Account Director, Medical Education
-
Salary TBC
- Entry Level Editorial Assistant – Medical Education –Buckinghams...
-
Highly Competitive
- Senior Editor - Medical Communications - South East - Buckingham...
-
Highly competitive salary &package
-
Account Director
-
Salary TBC
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
- OTC / Consumer Health PR Account Director
-
profit share, pens, life assurance more
Latest content from PMHub
- Publication planning excellence at Porterhouse Medical
-
Porterhouse Medical Group
- Patient journey mapping: exploring the clinical and the emotional journey
- By Chris Hodgson, Neil Rees, Sumira Riaz and Karen Petticrew While we can all agree that the value of developing a patient journey map cannot be underestimated when exploring the care pathway for a patient, there appear to be inconsistencies within the same pharmaceutical organisations as to how patient journey mapping is defined.
OPEN Health
- Precision medicine at Blue Latitude Health
- At Blue Latitude Health we have identified 90+ insights about commercialising precision medicines. Check out our video to get a run down on three core components of the commercialisation and launch of precision medicines.
Blue Latitude Health
- The first of many celebrations for Lucid Group at Middlesex House
-
Lucid Group Communications Limited
